Aethlon Medical Inc Total Liabilities
Aethlon Medical Inc total liabilities. Based on the latest financial reports, Aethlon Medical Inc (AEMD) has total liabilities worth $1.04 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Aethlon Medical Inc (AEMD) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Aethlon Medical Inc (1997–2026)
Total liabilities of Aethlon Medical Inc from 1997 to 2026. This chart illustrates how Aethlon Medical Inc's total liabilities have evolved over time, based on quarterly financial data.
Aethlon Medical Inc Competitors by Total Liabilities
The table below lists competitors of Aethlon Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
COPPERCORP RESOURCES INC.
F:NU0
|
Germany | €389.97K |
|
INCUVO S.A. ZY -50
F:68X
|
Germany | €2.42 Million |
|
GGX Gold Corp
V:GGX
|
Canada | CA$1.59 Million |
|
MultiMetaVerse Holdings Limited
NASDAQ:MMV
|
USA | $35.87 Million |
|
Stelmine Canada Ltd
V:STH
|
Canada | CA$616.27K |
|
Rover Metals Corp
V:ROVR
|
Canada | CA$992.88K |
|
Metavisio (Thomson Computing)
PA:ALTHO
|
France | €45.52 Million |
|
Alligator Bioscience AB
ST:ATORX
|
Sweden | Skr61.79 Million |
Liability Composition Analysis (1997–2026)
This chart breaks down Aethlon Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see AEMD total asset value.
Liquidity & Leverage Metrics
Aethlon Medical Inc Total Liabilities Ratios Explained
Aethlon Medical Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aethlon Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aethlon Medical Inc (1997–2026)
The table below shows the annual total liabilities of Aethlon Medical Inc from 1997 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | $1.45 Million | -35.29% |
| 2025-03-31 | $2.24 Million | -9.83% |
| 2024-03-31 | $2.48 Million | +1.43% |
| 2023-03-31 | $2.44 Million | +0.75% |
| 2022-03-31 | $2.43 Million | +76.45% |
| 2021-03-31 | $1.38 Million | +23.87% |
| 2020-03-31 | $1.11 Million | -39.13% |
| 2019-03-31 | $1.82 Million | +38.27% |
| 2018-03-31 | $1.32 Million | +16.64% |
| 2017-03-31 | $1.13 Million | +7.26% |
| 2016-03-31 | $1.05 Million | +44.59% |
| 2015-03-31 | $729.21K | -95.56% |
| 2014-03-31 | $16.43 Million | +70.37% |
| 2013-03-31 | $9.64 Million | -4.87% |
| 2012-03-31 | $10.13 Million | +54.89% |
| 2011-03-31 | $6.54 Million | +29.61% |
| 2010-03-31 | $5.05 Million | +21.74% |
| 2009-03-31 | $4.15 Million | +8.83% |
| 2008-03-31 | $3.81 Million | -50.55% |
| 2007-03-31 | $7.71 Million | +176.24% |
| 2006-03-31 | $2.79 Million | -17.17% |
| 2005-03-31 | $3.37 Million | -14.47% |
| 2004-03-31 | $3.94 Million | -2.17% |
| 2003-03-31 | $4.02 Million | +26.90% |
| 2002-03-31 | $3.17 Million | -15.44% |
| 2001-03-31 | $3.75 Million | +84.45% |
| 2000-03-31 | $2.03 Million | +158.47% |
| 1999-03-31 | $786.57K | +39645.78% |
| 1998-03-31 | $1.98K | +465.43% |
| 1997-03-31 | $350.00 | -- |
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.